Please login to the form below

Not currently logged in
Email:
Password:

belinostat

This page shows the latest belinostat news and features for those working in and with pharma, biotech and healthcare.

AZ signs two more deals in cancer immunotherapy

AZ signs two more deals in cancer immunotherapy

The latter is in the same class as Merck &Co's Zolinza (vorinostat), Novartis' Farydak (panobinostat) and Spectrum Pharmaceuticals' Beleodaq (belinostat), which are approved for various haematological cancers.

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Spectrum appoints chief medical officer Spectrum appoints chief medical officer

    Dr Allen will lead the development of the US-based biotech's pipeline of products, including its investigational cancer drug belinostat, which is due to be filed for approval in

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics